Effectiveness of Classical Music Therapy on Decreasing the Level of Auditory Hallucinations in Schizophrenia Patients: A Literature Review
Downloads
Introduction: Hallucinations are one of the symptoms most often experienced by schizophrenia patients. Auditory hallucinations affect about 70% of schizophrenia patients who experience hallucinations. Classical music therapy is one of the non-pharmacological interventions that can be done. Music can be used as a non-pharmacological therapy option because it can improve, restore and maintain physical, mental, emotional, social and spiritual health. Objective: This study aims to further discuss the effectiveness of classical music therapy in reducing the level of auditory hallucinations in schizophrenia patients. Methods: This study uses the literature review method by searching research data on Google Scholar database. Result: Based on the result of the data search, 8 journals were studied in this study. Discussion: The result found in 8 journals stated that classical music therapy as a non-pharmacological therapy can reduce the intensity of auditory hallucinations in schizophrenia patients. Classical music can evoke changes at the level of important neuromodulators such as dopamine, endorphins, endogenous cannabinoids and nitric oxide. So that the administration of classical music theraoy can eliminate the neurotransmitters of depression, stress, anxiety, and can suppress the symptoms of hallucinations including auditory hallucinations. Conclusion: This study concluded that classical music therapy is effective in reducing the level of auditory hallucinations in schizophrenia patients.
Keyword: Classical music therapy, Hallucinations, Schizophrenia
Copyright (c) 2023 Fiki Muhammad Ridho
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. Copyright of this journal is possession of the Author, by the knowledge of the Editorial Board and Journal Manager, while the moral right of the publication belongs to the author.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The articles are published under a Creative Commons Attribution Share-Alike (CC BY-SA) license. Many research funding bodies prefer the CC BY-SA license because it allows for maximum dissemination and re-use of open access materials. Users are free to share (copy, distribute, and transmit) and remix (adapt) the contribution under this license, including for commercial purposes, as long as they attribute the contribution in the manner specified by the author or licensor.